Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

Caitlin E. Cox

December 05, 2017

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

News Daily News

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Michael O'Riordan

October 24, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

Another Study Challenges Notion of ‘Healthy Obese’

L.A. McKeown

September 11, 2017

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale

August 27, 2017

News Daily News

Smoking Cessation Drugs: Missed Opportunity for Patients Hospitalized for CHD

Caitlin E. Cox

August 23, 2017

News Daily News

3-D Ultrasound Quantifies Plaque Burden in Healthy Middle-Aged Cohort

Michael O'Riordan

July 11, 2017

News Daily News

Shingles Strongly Tied to Increase in MI and Stroke Risks

Ashley Lyles

July 06, 2017

News Daily News

Higher BMI Linked to Increased Risk of CHD, Hypertension, and Diabetes

Michael O'Riordan

July 06, 2017

News Daily News

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Yael L. Maxwell

June 16, 2017

News Daily News

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

Michael O'Riordan

June 09, 2017

News Daily News

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

L.A. McKeown

May 03, 2017

News Daily News

Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling

L.A. McKeown

May 01, 2017

News Daily News

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

Michael O'Riordan

April 04, 2017

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

News Conference News ISET 2017

Routine Screening of ABI to Identify PAD: Despite Guidelines, One Expert Asks Why Not?

Caitlin E. Cox

February 06, 2017

Advertisement

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Another Study Challenges Notion of ‘Healthy Obese’

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Smoking Cessation Drugs: Missed Opportunity for Patients Hospitalized for CHD

3-D Ultrasound Quantifies Plaque Burden in Healthy Middle-Aged Cohort

Shingles Strongly Tied to Increase in MI and Stroke Risks

Higher BMI Linked to Increased Risk of CHD, Hypertension, and Diabetes

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Routine Screening of ABI to Identify PAD: Despite Guidelines, One Expert Asks Why Not?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content